Sign in

CIK 0001517022

  • Large accelerated filer

Akebia Therapeutics, Inc.

Sign in to watch
Ticker
AKBA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
208756903
Phone
+1 617-871-2098
Business address
180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4/A Derivatives Options or other derivatives
  9. 4 Open-market sale SVP, General Counsel, Sec. sold 1,556 shares at $9.41 ($14,642)
  10. 4 Open-market sale SVP, Chief Business Officer sold 1,401 shares at $9.41 ($13,183)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Grant or award SVP and Chief Medical Officer acquired 36,500 shares (grant or award)
  13. 4 Grant or award SVP, General Counsel, Sec. acquired 22,500 shares (grant or award)
  14. 4 Grant or award CEO and President acquired 125,500 shares (grant or award)
  15. 4 Grant or award SVP, CFO & Treasurer acquired 26,000 shares (grant or award)
  16. 4 Exercise or conversion CEO and President acquired 25,000 shares (option exercise)
  17. 4 Open-market sale SVP, General Counsel, Sec. sold 1,811 shares at $12.28 ($22,239)
  18. 4 Open-market sale Director sold 996 shares at $8.65 ($8,617)
  19. 4 Open-market sale SVP, General Counsel, Sec. sold 1,484 shares at $8.67 ($12,860)
  20. 4 Open-market sale Director sold 996 shares at $9.53 ($9,490)

Page 15 of 19 · 378 filings